Literature DB >> 32556599

Full genome sequence of the first SARS-CoV-2 detected in Mexico.

Fabiola Garcés-Ayala1, Adnan Araiza-Rodríguez1, Edgar Mendieta-Condado1, Abril Paulina Rodríguez-Maldonado1, Claudia Wong-Arámbula1, Magaly Landa-Flores1, Juan Carlos Del Mazo-López1, Maribel González-Villa1, Noé Escobar-Escamilla1, David Esaú Fragoso-Fonseca1, María Del Carmen Esteban-Valencia1, Lourdes Lloret-Sánchez1, Dayanira Sarith Arellano-Suarez1, Tatiana Ernestina Nuñez-García1, Nervain Benjamin Contreras-González1, Natividad Cruz-Ortiz1, Adriana Ruiz-López1, Miguel Ángel Fierro-Valdez1, Daniel Regalado-Santiago1, Nancy Martínez-Velázquez1, Mireya Mederos-Michel1, Joel Vázquez-Pérez2, José Arturo Martínez-Orozco2, Eduardo Becerril-Vargas2, Jorge Salas2, Lucía Hernández-Rivas1, Irma López-Martínez1, José Luis Alomía-Zegarra3, Hugo López-Gatell4, Gisela Barrera-Badillo5, José Ernesto Ramírez-González6.   

Abstract

SARS-CoV-2 was first detected in the city of Wuhan, Hubei Province, China. In this report, we describe the complete genome sequence of the first imported SARS-CoV-2, detected in a Mexican patient who had traveled to Bergamo, Italy. Phylogenetic analysis showed that this isolate belongs to subclade A2a (lineage G) and is closely related to isolates from Finland, Germany and Brazil, all of which were from patients with a history of travel to Italy. This is the first report of the complete genome sequence of this virus in Mexico.

Entities:  

Mesh:

Year:  2020        PMID: 32556599      PMCID: PMC7300367          DOI: 10.1007/s00705-020-04695-3

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


Virus name: hCoV/Mexico/CDMX/InDRE_01/2020 GISAID accession ID: EPI_ISL_412972 A novel coronavirus, recently named severe acute respiratory syndrome-related coronavirus type 2 (SARS-CoV-2), was identified in the city of Wuhan, Hubei Province, China, in December of 2019 It is betacoronavirus that affects the lower respiratory tract and manifests as pneumonia in humans [1, 2]. According to the Johns Hopkins University Coronavirus Resource Center and the Daily Technical Statement on New Coronavirus Cases Worldwide (COVID-19) issued by the Secretary of Health of Mexico, as of March 20, 2020, 234,072 confirmed cases have been reported worldwide with 9840 deaths. In Mexico, 203 cases have been confirmed, with two deaths reported [3, 4]. At the time of this writing, 768 complete genomic sequences of SARS Cov-2 have been obtained and deposited in the GISAID database, and 10 clades have been defined from phylogenetic studies carried out with these sequences (A1, A1a, A2, A2a, A3, A5, B, B1, B2 and B4) [5]. Here, we report the complete genome sequence of SARS-CoV-2 from the first imported case of COVID-19 detected in Mexico. The sample hCoV/Mexico/CDMX/InDRE_01/2020 was obtained directly from a nasopharyngeal swab from a 35-year-old male patient (InDRE 1198) residing in Mexico City who had a confirmed diagnosis of SARS-CoV-2 on February 27, 2020 and had traveled to Bergamo, Italy, between February 16 and 22, 2020. A diagnostic test for COVID-19 was first conducted at the Instituto Nacional de Enfermedades Respiratorias, Mexico City, on February 27, 2020. Following the national guidelines of the Mexican Ministry of Health [6], a sample was sent to the National Influenza Center at the Instituto de Diagnostico y Referencia Epidemiologicos (InDRE); the confirmatory diagnosis was conducted using a real-time RT-PCR protocol to detect SARS-CoV-2 [7], and of a 221-bp fragment of the region coding for the orf1ab polyprotein was sequenced by the Sanger method and will be published elsewhere. The sample from the patient had a cycle threshold value of 19.5 for the E gene and 20.4 for the RdRP gene. The complete virus genome from the positive case was amplified using the novel coronavirus sequencing multiplex primers [8] (https://artic.network/ncov-2019). cDNA synthesis was conducted using Super Script IV Reverse Transcriptase (Invitrogen) and the concentration of PCR the product was measured using a Qubit dsDNA High Sensitivity Kit on a Qubit 3.0 fluorometer (Thermo Fisher) and an Agilent 2100 Bioanalyzer (Agilent Technologies). A library without barcodes was generated and sequenced using an Ion Torrent system, using an Ion Xpress™ Plus Fragment Library Kit for sequencing on an Ion 318™ v2 chip. A total of 1,445,751 reads were obtained for hCov/Mexico/CDMX/InDRE_01/2020. The complete genome sequence was assembled using CLC Genomics Workbench 20 (QIAGEN) and SPAdes [9] and mapped against the reference sequence Wuhan-Hu-1 (GenBank accession number NC_045512.2). The consensus sequence was assembled into a single contig with a total length of 29,849 bp, corresponding to 99.8% of genome, and a deep average coverage of 3,983X. The sequence was deposited in the GISAID database [5] under accession ID EPI_ISL_412972. A database was constructed including 178 genomic sequences available on the GISAID platform, obtained from December 31, 2019 to March 05, 2020, reported in 22 countries. A phylogenetic tree was constructed in MEGA 6 software using the neighbor-joining method and the Kimura 2-parameter evolution model with 100 bootstrap replicates [10]. The strain hCoV/Mexico/CDMX/InDRE_01/2020 was grouped in the clade A2 subclade A2a (also called lineage G) and is closely related to isolates from Finland, Italy, and Germany as well as an isolate from the first imported SARS-CoV-2 case in Brazil [11] (Fig. 1).
Fig. 1

Neighbor-joining tree constructed in MEGA using the Kimura 2-parameter evolution model with 100 bootstrap replicates. hCoV/Mexico/CDMX/InDRE_01/2020 (indicated by an arrow) is grouped in clade A2a with sequences previously reported from Brazil, Germany, Italy, and Finland. The 14408C>T substitution is characteristic of subclade A2a

Neighbor-joining tree constructed in MEGA using the Kimura 2-parameter evolution model with 100 bootstrap replicates. hCoV/Mexico/CDMX/InDRE_01/2020 (indicated by an arrow) is grouped in clade A2a with sequences previously reported from Brazil, Germany, Italy, and Finland. The 14408C>T substitution is characteristic of subclade A2a Genetic analysis showed that the hCoV/Mexico/CDMX/InDRE_01/2020 genome differs by seven nucleotide substitutions compared to the Wuhan-Hu-1 reference strain: 241C>T, 3037C>T, 14408C>T, 23403A>G, 28881G>A, 28882G>A, and 28883G>C. We confirmed the presence of the 14408C>T substitution, which is characteristic of the sequences clustered in subclade A2a. A second database of 768 sequences deposited until March 20, 2020, was used to construct a phylogenetic tree. This analysis showed that hCoV/Mexico/CDMX/InDRE_01/2020 clusters with European lineage G sequences, mainly from Belgium, Switzerland, and England (Fig. 2). This finding correlates with the transmission events reported by GISAID [5], which suggest that this strain was first introduced into Belgium, then England, and finally, Italy, where the Mexican patient had been traveling.
Fig. 2

Neighbor-joining tree constructed with 768 sequences available in the GISAID database on March 20, 2020. The analysis shows that the Mexican strain (indicated by an arrow) clusters with European sequences, corroborating the transmission events reported by GISAID (Belgium-Germany-Italy-Mexico) for this first imported case in our country

Neighbor-joining tree constructed with 768 sequences available in the GISAID database on March 20, 2020. The analysis shows that the Mexican strain (indicated by an arrow) clusters with European sequences, corroborating the transmission events reported by GISAID (Belgium-Germany-Italy-Mexico) for this first imported case in our country This is the first report of the complete genome of this virus in our country, and these data will contribute to the molecular epidemiology of the SARS-CoV-2.
  5 in total

1.  SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing.

Authors:  Anton Bankevich; Sergey Nurk; Dmitry Antipov; Alexey A Gurevich; Mikhail Dvorkin; Alexander S Kulikov; Valery M Lesin; Sergey I Nikolenko; Son Pham; Andrey D Prjibelski; Alexey V Pyshkin; Alexander V Sirotkin; Nikolay Vyahhi; Glenn Tesler; Max A Alekseyev; Pavel A Pevzner
Journal:  J Comput Biol       Date:  2012-04-16       Impact factor: 1.479

2.  MEGA6: Molecular Evolutionary Genetics Analysis version 6.0.

Authors:  Koichiro Tamura; Glen Stecher; Daniel Peterson; Alan Filipski; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2013-10-16       Impact factor: 16.240

3.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

4.  Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.

Authors:  Victor M Corman; Olfert Landt; Marco Kaiser; Richard Molenkamp; Adam Meijer; Daniel Kw Chu; Tobias Bleicker; Sebastian Brünink; Julia Schneider; Marie Luisa Schmidt; Daphne Gjc Mulders; Bart L Haagmans; Bas van der Veer; Sharon van den Brink; Lisa Wijsman; Gabriel Goderski; Jean-Louis Romette; Joanna Ellis; Maria Zambon; Malik Peiris; Herman Goossens; Chantal Reusken; Marion Pg Koopmans; Christian Drosten
Journal:  Euro Surveill       Date:  2020-01

5.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

  5 in total
  9 in total

1.  Genomic Analysis of Early SARS-CoV-2 Variants Introduced in Mexico.

Authors:  Blanca Taboada; Joel Armando Vazquez-Perez; José Esteban Muñoz-Medina; Pilar Ramos-Cervantes; Marina Escalera-Zamudio; Celia Boukadida; Alejandro Sanchez-Flores; Pavel Isa; Edgar Mendieta-Condado; José A Martínez-Orozco; Eduardo Becerril-Vargas; Jorge Salas-Hernández; Ricardo Grande; Carolina González-Torres; Francisco Javier Gaytán-Cervantes; Gloria Vazquez; Francisco Pulido; Adnan Araiza-Rodríguez; Fabiola Garcés-Ayala; Cesar Raúl González-Bonilla; Concepción Grajales-Muñiz; Víctor Hugo Borja-Aburto; Gisela Barrera-Badillo; Susana López; Lucía Hernández-Rivas; Rogelio Perez-Padilla; Irma López-Martínez; Santiago Ávila-Ríos; Guillermo Ruiz-Palacios; José Ernesto Ramírez-González; Carlos F Arias
Journal:  J Virol       Date:  2020-08-31       Impact factor: 5.103

2.  Impact of layered non-pharmacological interventions on COVID-19 transmission dynamics in Yucatan, Mexico.

Authors:  G Ayora-Talavera; P Granja-Perez; M Sauri-Vivas; C I Hernández-Fuentes; I P Hennessee; I López-Martínez; G Barrera-Badillo; A Che-Mendoza; P Manrique-Saide; J A Clennon; H Gómez-Dantés; G Vazquez-Prokopec
Journal:  Prev Med Rep       Date:  2022-05-24

3.  SARS-CoV-2 sequencing: The technological initiative to strengthen early warning systems for public health emergencies in Latin America and the Caribbean

Authors:  Diego A Álvarez-Díaz; Katherine Laiton-Donato; Carlos Franco-Muñoz; Marcela Mercado-Reyes
Journal:  Biomedica       Date:  2020-10-30       Impact factor: 0.935

Review 4.  Cross-disciplinary approaches to assist with nucleic acid testing for SARS-CoV-2.

Authors:  Shujuan Yang; Xiongfeng Pan; Dan Yuan; Peibin Zeng; Peng Jia
Journal:  Appl Microbiol Biotechnol       Date:  2021-08-23       Impact factor: 4.813

5.  Phylogenetic and full-length genome mutation analysis of SARS-CoV-2 in Indonesia prior to COVID-19 vaccination program in 2021.

Authors:  Reviany V Nidom; Setyarina Indrasari; Irine Normalina; Astria N Nidom; Balqis Afifah; Lestari Dewi; Andra K Putra; Arif N M Ansori; Muhammad K J Kusala; Mohammad Y Alamudi; Chairul A Nidom
Journal:  Bull Natl Res Cent       Date:  2021-11-21

6.  Genomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission.

Authors:  Andrew J Page; Ulf Schaefer; Dinesh Aggarwal; George M Savva; Richard Myers; Erik Volz; Nicholas Ellaby; Steven Platt; Natalie Groves; Eileen Gallagher; Niamh M Tumelty; Thanh Le Viet; Gareth J Hughes; Cong Chen; Charlie Turner; Sophie Logan; Abbie Harrison; Sharon J Peacock; Meera Chand; Ewan M Harrison
Journal:  Nat Commun       Date:  2022-02-23       Impact factor: 14.919

7.  Genetic Analysis of SARS-CoV-2 Variants in Mexico during the First Year of the COVID-19 Pandemic.

Authors:  Blanca Taboada; Selene Zárate; Pavel Iša; Celia Boukadida; Joel Armando Vazquez-Perez; José Esteban Muñoz-Medina; José Ernesto Ramírez-González; Andreu Comas-García; Concepción Grajales-Muñiz; Alma Rincón-Rubio; Margarita Matías-Florentino; Alejandro Sanchez-Flores; Edgar Mendieta-Condado; Jerome Verleyen; Gisela Barrera-Badillo; Lucía Hernández-Rivas; Fidencio Mejía-Nepomuceno; José Arturo Martínez-Orozco; Eduardo Becerril-Vargas; Susana López; Irma López-Martínez; Santiago Ávila-Ríos; Carlos F Arias
Journal:  Viruses       Date:  2021-10-26       Impact factor: 5.048

8.  The spreading of Covid-19 in Mexico: A diffusional approach.

Authors:  Carlos G Aguilar-Madera; Gilberto Espinosa-Paredes; E C Herrera-Hernández; Jorge A Briones Carrillo; J Valente Flores-Cano; Víctor Matías-Pérez
Journal:  Results Phys       Date:  2021-07-16       Impact factor: 4.476

9.  Analysis of SARS-CoV-2 mutations in Mexico, Belize, and isolated regions of Guatemala and its implication in the diagnosis.

Authors:  María Teresa Hernández-Huerta; Laura Pérez-Campos Mayoral; Carlos Romero Díaz; Margarito Martínez Cruz; Gabriel Mayoral-Andrade; Luis Manuel Sánchez Navarro; María Del Socorro Pina-Canseco; Eli Cruz Parada; Ruth Martínez Cruz; Eduardo Pérez-Campos Mayoral; Alma Dolores Pérez Santiago; Gabriela Vásquez Martínez; Eduardo Pérez-Campos; Carlos Alberto Matias-Cervantes
Journal:  J Med Virol       Date:  2020-11-01       Impact factor: 20.693

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.